SciELO - Scientific Electronic Library Online

 
vol.45 número1Evaluación de la citotoxidad del trióxido de arsénico en líneas celulares tumorales humanas con la técnica colorimétrica de la sulforhodamina BInfecciones nosocomiales: incidencia de la Pseudomonas aeruginosa índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Medicina

versión impresa ISSN 0034-7523versión On-line ISSN 1561-302X

Resumen

HERNANDEZ CRUZ, Calixto et al. Tratamiento con quimioterapia de la leucemia mieloide aguda en el Hospital “Hermanos Ameijeiras.” Experiencia de 20 años de trabajo. Rev cubana med [online]. 2006, vol.45, n.1. ISSN 0034-7523.

Acute myeloid leukaemia (AML) represents 80% of the total number of acute leukemia affecting human beings and its prognosis remains very unfavourable. This paper was aimed at showing the experience accrued by the hospital in the presentation and treatment of this disease with the use of chemotherapy. The results achieved in the treatment of 193 cases diagnosed with AML and treated at the Hematology Service for 20 years were analyzed. Average age of patients was 42.7 years and the most frequent FAB subtype was M2. Non M3 AML cases showed a complete remission index of 45.5% for all the age groups and of 60.4% for under 60 year-olds. The global survival rate was 8.9% after 5 years of follow-up for patients under 60 years, without survivors for the same length of time in the over 60 years-old group. Complication-free survival was 16.2% in general at 5 years of follow-up. The patients with M3 AML had a complete remission index of 75%.  Global survival and complication-free survival at 5 years were 40.4% and 62.2% respectively. The 67.7% of cases died from a disease resistant to treatment or from a relapse.

Palabras clave : Acute myeloid leukaemia; complete remission; global survival rate; complication-free survival rate.

        · resumen en Español     · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons